F. Dayyani, B. Czerniak, and K. Sircar, Plasmacytoid Urothelial Carcinoma, a Chemosensitive Cancer with Poor Prognosis, and Peritoneal Carcinomatosis, The Journal of Urology, vol.189, issue.5, pp.1656-61, 2013.
DOI : 10.1016/j.juro.2012.11.084
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243847

A. Kamat, C. Dinney, and J. Gee, Micropapillary bladder cancer, Cancer, vol.106, issue.1, pp.62-69, 2007.
DOI : 10.1002/cncr.22756

C. Ching, M. Amin, and R. Tubbs, HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization, Modern Pathology, vol.25, issue.8, pp.1111-1120, 2011.
DOI : 10.1200/JCO.2006.08.0994

H. Al-ahmadie, G. Iyer, and B. Lee, Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer, Nature Genetics, vol.80, issue.4, pp.356-364, 2016.
DOI : 10.1038/nmeth.3047

J. Earl, D. Rico, and E. Carrillo-de-santa-pau, The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies, BMC Genomics, vol.65, issue.2, p.403, 2015.
DOI : 10.1016/j.eururo.2013.08.057

M. Liebert, G. Wedemeyer, and J. Chang, Comparison of Antigen Expression on Normal Urothelial Cells in Tissue Section and Tissue Culture, The Journal of Urology, vol.144, issue.5, pp.1288-92, 1990.
DOI : 10.1016/S0022-5347(17)39721-5

B. Christian, L. Loretz, T. Oberley, and C. Reznikoff, Characterization of human uroepithelial cells immortalized in vitro by simian virus 40, Cancer Res, vol.47, pp.6066-73, 1987.

E. Chapman, C. Hurst, E. Pitt, P. Chambers, J. Aveyard et al., Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16/Rb pathway, Oncogene, vol.12, issue.36, pp.5037-5082, 2006.
DOI : 10.1128/MCB.12.12.5581

W. Choi, S. Porten, and S. Kim, Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy, Cancer Cell, vol.25, issue.2, pp.152-65, 2014.
DOI : 10.1016/j.ccr.2014.01.009

E. Lee, G. Jinesh, N. Laing, W. Choi, D. Mcconkey et al., A Smac mimetic augments the response of urothelial cancer cells to gemcitabine and cisplatin, Cancer Biology & Therapy, vol.120, issue.9, pp.812-834, 2013.
DOI : 10.1093/bioinformatics/19.2.185

R. Simon, S. Geyer, J. Subramanian, and S. Roychowdhury, The Bayesian basket design for genomic variant-driven phase II trials, Seminars in Oncology, vol.43, issue.1, pp.13-21, 2016.
DOI : 10.1053/j.seminoncol.2016.01.002

D. Gao, I. Vela, and A. Sboner, Organoid Cultures Derived from Patients with Advanced Prostate Cancer, Cell, vol.159, issue.1, pp.176-87, 2014.
DOI : 10.1016/j.cell.2014.08.016
URL : http://doi.org/10.1016/j.cell.2014.08.016

J. Drost, W. Karthaus, and D. Gao, Organoid culture systems for prostate epithelial and cancer tissue, Nature Protocols, vol.945, issue.2, pp.347-58, 2016.
DOI : 10.1126/science.1112521
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793718

T. Kobayashi, T. Owczarek, J. Mckiernan, and C. Abate-shen, Modelling bladder cancer in mice: opportunities and challenges, Nature Reviews Cancer, vol.7, issue.1, pp.42-54, 2015.
DOI : 10.1371/journal.pone.0035243
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386904

X. Wu, Urothelial tumorigenesis: a tale of divergent pathways, Nature Reviews Cancer, vol.26, issue.9, pp.713-738, 2005.
DOI : 10.1038/nrc777

X. Wu, Biology of urothelial tumorigenesis: insights from genetically engineered mice, Cancer and Metastasis Reviews, vol.63, issue.3-4, pp.281-90, 2009.
DOI : 10.1016/S0002-9440(10)64594-4

I. Ahmad, L. Singh, and M. Foth, K-Ras and ??-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder, Disease Models & Mechanisms, vol.4, issue.4, pp.548-55, 2011.
DOI : 10.1242/dmm.006874

X. Chen, N. Mitsutake, and K. Laperle, Endogenous expression of HrasG12V induces developmental defects and neoplasms with copy number imbalances of the oncogene, Proceedings of the National Academy of Sciences, vol.88, issue.5, pp.7979-84, 2009.
DOI : 10.1016/S0092-8674(00)81902-9

H. Zhou, X. Wang, and L. Mo, Role of isoenzyme M2 of pyruvate kinase in urothelial tumorigenesis, Oncotarget, vol.7, issue.17, pp.23947-60, 2016.
DOI : 10.18632/oncotarget.8114

X. Wu, C. Mendelsohn, and D. Degraff, Tumorigenicity of RTK/RAS in urothelium, Oncoscience, vol.2, pp.739-779, 2015.
DOI : 10.18632/oncoscience.188

J. Gao, H. Huang, and J. Pak, p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis, Oncogene, vol.23, issue.3, pp.687-96, 2004.
DOI : 10.1038/sj.onc.1207169
URL : http://www.nature.com/onc/journal/v23/n3/pdf/1207169a.pdf

F. He, L. Mo, and X. Zheng, Deficiency of pRb Family Proteins and p53 in Invasive Urothelial Tumorigenesis, Cancer Research, vol.69, issue.24, pp.9413-9434, 2009.
DOI : 10.1158/0008-5472.CAN-09-2158

A. Puzio-kuter, M. Castillo-martin, and C. Kinkade, Inactivation of p53 and Pten promotes invasive bladder cancer, Genes & Development, vol.23, issue.6, pp.675-80, 2009.
DOI : 10.1101/gad.1772909

E. Chan, A. Patel, W. Heston, and W. Larchian, Mouse orthotopic models for bladder cancer research, BJU International, vol.26, issue.Suppl., pp.1286-91, 2009.
DOI : 10.1016/S0002-9440(10)64594-4

H. Zdimerova, M. Albert, and M. Ingersoll, Harnessing the Host Immune Response to Infection ??? BCG Immunotherapy for Bladder Cancer, Infection and Cancer: Bi-Directorial Interactions, pp.387-403
DOI : 10.1007/978-3-319-20669-1_18

C. Biot, C. Rentsch, and J. Gsponer, Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer, Science Translational Medicine, vol.147, issue.12, pp.137-72, 2012.
DOI : 10.4049/jimmunol.0803974
URL : https://hal.archives-ouvertes.fr/pasteur-01402032

S. Lerner and A. Robertson, Molecular Subtypes of Non-muscle Invasive Bladder Cancer, Cancer Cell, vol.30, issue.1, pp.1-3, 2016.
DOI : 10.1016/j.ccell.2016.06.012

J. Hedegaard, P. Lamy, and I. Nordentoft, Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma, Cancer Cell, vol.30, issue.1, pp.27-42, 2016.
DOI : 10.1016/j.ccell.2016.05.004

J. Rosenberg, J. Hoffman-censits, and T. Powles, Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial, The Lancet, vol.387, issue.10031, pp.1909-1929, 2016.
DOI : 10.1016/S0140-6736(16)00561-4

A. Morales, D. Eidinger, and A. Bruce, Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors, The Journal of Urology, vol.116, issue.2, pp.180-183, 1976.
DOI : 10.1016/S0022-5347(17)58737-6

S. Williams, C. Hurst, and M. Knowles, Oncogenic FGFR3 gene fusions in bladder cancer, Human Molecular Genetics, vol.22, issue.4, pp.795-803, 2013.
DOI : 10.1093/hmg/dds486
URL : https://academic.oup.com/hmg/article-pdf/22/4/795/13930928/dds486.pdf

R. Morgan, T. Synold, and J. Longmate, Pharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trial, Cancer Chemotherapy and Pharmacology, vol.7, issue.3, pp.897-907, 2015.
DOI : 10.1097/JTO.0b013e31823f43ca

P. Challita-eid, D. Satpayev, and P. Yang, Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models, Cancer Research, vol.76, issue.10, pp.3003-3016, 2016.
DOI : 10.1158/0008-5472.CAN-15-1313

P. Khandelwal, S. Abraham, and G. Apodaca, Cell biology and physiology of the uroepithelium, AJP: Renal Physiology, vol.297, issue.6, pp.1477-501, 2009.
DOI : 10.1152/ajprenal.00327.2009

X. Wu, X. Kong, A. Pellicer, G. Kreibich, and T. Sun, Uroplakins in urothelial biology, function, and disease, Kidney International, vol.75, issue.11, pp.1153-65, 2009.
DOI : 10.1038/ki.2009.73
URL : http://doi.org/10.1038/ki.2009.73

D. Gandhi, A. Molotkov, and E. Batourina, Retinoid Signaling in Progenitors Controls Specification and Regeneration of the Urothelium, Developmental Cell, vol.26, issue.5, pp.469-82, 2013.
DOI : 10.1016/j.devcel.2013.07.017

R. Airik and A. Kispert, Down the tube of obstructive nephropathies: The importance of tissue interactions during ureter development, Kidney International, vol.72, issue.12, pp.1459-67, 2007.
DOI : 10.1038/sj.ki.5002589

T. Yamany, J. Van-batavia, and C. Mendelsohn, Formation and regeneration of the urothelium, Current Opinion in Organ Transplantation, vol.19, issue.3, pp.323-353, 2014.
DOI : 10.1097/MOT.0000000000000084

K. Georgas, J. Armstrong, and J. Keast, An illustrated anatomical ontology of the developing mouse lower urogenital tract, Development, vol.142, issue.10, pp.1893-908, 2015.
DOI : 10.1242/dev.117903

G. Papafotiou, V. Paraskevopoulou, E. Vasilaki, Z. Kanaki, N. Paschalidis et al., KRT14 marks a subpopulation of bladder basal cells with pivotal role in regeneration and tumorigenesis, Nature Communications, vol.26, p.11914, 2016.
DOI : 10.1007/s00418-005-0104-y

H. Moch, A. Cubilla, P. Humphrey, V. Reuter, and T. Ulbright, The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs???Part A: Renal, Penile, and Testicular Tumours, European Urology, vol.70, issue.1, pp.93-105, 2016.
DOI : 10.1016/j.eururo.2016.02.029

J. Van-batavia, T. Yamany, and A. Molotkov, Bladder cancers arise from distinct urothelial sub-populations, Nature Cell Biology, vol.161, issue.10, pp.982-91, 2014.
DOI : 10.1038/356215a0

K. Shin, J. Lee, and N. Guo, Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder, Nature, vol.341, issue.7341, pp.110-114, 2011.
DOI : 10.1097/01.ju.0000141585.17953.fa

K. Shin, A. Lim, and J. Odegaard, Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma, Nature Cell Biology, vol.59, issue.5, pp.469-78, 2014.
DOI : 10.1016/S0959-8049(01)00118-6

A. Califano and M. Alvarez, The recurrent architecture of tumour initiation, progression and drug sensitivity, Nature Reviews Cancer, vol.31, issue.2, pp.116-146, 2016.
DOI : 10.1038/nrclinonc.2013.197

D. Degraff, J. Cates, J. Mauney, P. Clark, R. Matusik et al., When urothelial differentiation pathways go wrong: Implications for bladder cancer development and progression, Urologic Oncology: Seminars and Original Investigations, vol.31, issue.6, pp.802-813, 2013.
DOI : 10.1016/j.urolonc.2011.07.017

M. Lawrence, P. Stojanov, and C. Mermel, Discovery and saturation analysis of cancer genes across 21 tumour types, Nature, vol.505, issue.7484, pp.495-501, 2014.
DOI : 10.1002/ijc.25516

D. Lindgren, G. Sjödahl, and M. Lauss, Integrated Genomic and Gene Expression Profiling Identifies Two Major Genomic Circuits in Urothelial Carcinoma, PLoS ONE, vol.21, issue.6, p.38863, 2012.
DOI : 10.1371/journal.pone.0038863.s008
URL : http://doi.org/10.1371/journal.pone.0038863

G. Sjodahl, M. Lauss, and K. Lovgren, A Molecular Taxonomy for Urothelial Carcinoma, Clinical Cancer Research, vol.18, issue.12, pp.3377-86, 2012.
DOI : 10.1158/1078-0432.CCR-12-0077-T
URL : http://clincancerres.aacrjournals.org/content/clincanres/18/12/3377.full.pdf

W. Choi, B. Czerniak, and A. Ochoa, Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer, Nature Reviews Urology, vol.8, issue.7, pp.400-410, 2014.
DOI : 10.1073/pnas.0610292104

C. Hurst and M. Knowles, Molecular Subtyping of Invasive Bladder Cancer: Time to Divide and Rule?, Cancer Cell, vol.25, issue.2, pp.135-141, 2014.
DOI : 10.1016/j.ccr.2014.01.026

K. Hoadley, C. Yau, and D. Wolf, Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin, Cell, vol.158, issue.4, pp.929-973, 2014.
DOI : 10.1016/j.cell.2014.06.049

C. Morrison, P. Liu, and A. Woloszynska-read, Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancer, Proceedings of the National Academy of Sciences, vol.111, issue.6, pp.672-81, 2014.
DOI : 10.1158/0008-5472.CAN-11-1403

D. Baris, M. Karagas, and C. Verrill, A Case???Control Study of Smoking and Bladder Cancer Risk: Emergent Patterns Over Time, JNCI: Journal of the National Cancer Institute, vol.101, issue.22, pp.1553-61, 2009.
DOI : 10.1093/jnci/djp361

M. Dorak and E. Karpuzoglu, Gender Differences in Cancer Susceptibility: An Inadequately Addressed Issue, Frontiers in Genetics, vol.3, p.268, 2012.
DOI : 10.3389/fgene.2012.00268
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508426

G. Edgren, L. Liang, H. Adami, and E. Chang, Enigmatic sex disparities in cancer incidence, European Journal of Epidemiology, vol.20, issue.6, pp.187-96, 2012.
DOI : 10.1016/j.bpg.2006.05.009

N. Freedman, D. Silverman, A. Hollenbeck, A. Schatzkin, and C. Abnet, Association Between Smoking and Risk of Bladder Cancer Among Men and Women, JAMA, vol.306, issue.7, pp.737-782, 2011.
DOI : 10.1001/jama.2011.1142

P. Soubeyran, K. Kowanetz, I. Szymkiewicz, W. Langdon, and I. Dikic, Cbl???CIN85???endophilin complex mediates ligand-induced downregulation of EGF receptors, Nature, vol.271, issue.6877, pp.183-190, 2002.
DOI : 10.1091/mbc.11.11.4019

A. Petrelli, G. Gilestro, S. Lanzardo, P. Comoglio, N. Migone et al., The endophilin???CIN85???Cbl complex mediates ligand-dependent downregulation of c-Met, Nature, vol.111, issue.6877, pp.187-90, 2002.
DOI : 10.1128/MCB.17.2.799

E. Shamir and A. Ewald, Three-dimensional organotypic culture: experimental models of mammalian biology and disease, Nature Reviews Molecular Cell Biology, vol.13, issue.10, pp.647-64, 2014.
DOI : 10.1016/j.stem.2013.11.002

K. Nguyen-ngoc, E. Shamir, R. Huebner, J. Beck, K. Cheung et al., 3D Culture Assays of Murine Mammary Branching Morphogenesis and Epithelial Invasion, Methods Mol Biol, vol.1189, pp.135-62, 2015.
DOI : 10.1007/978-1-4939-1164-6_10
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750493

E. Shamir, E. Pappalardo, and D. Jorgens, Twist1-induced dissemination preserves epithelial identity and requires E-cadherin, The Journal of Cell Biology, vol.11, issue.5, pp.839-56, 2014.
DOI : 10.1186/gb-2003-4-10-r69
URL : http://jcb.rupress.org/content/jcb/204/5/839.full.pdf

K. Cheung, E. Gabrielson, Z. Werb, and A. Ewald, Collective Invasion in Breast Cancer Requires a Conserved Basal Epithelial Program, Cell, vol.155, issue.7, pp.1639-51, 2013.
DOI : 10.1016/j.cell.2013.11.029
URL : http://doi.org/10.1016/j.cell.2013.11.029

K. Cheung and A. Ewald, A collective route to metastasis: Seeding by tumor cell clusters, Science, vol.527, issue.7, pp.167-176, 2016.
DOI : 10.1038/nature15748

K. Cheung, V. Padmanaban, and V. Silvestri, Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters, Proceedings of the National Academy of Sciences, vol.8, issue.6, pp.854-63, 2016.
DOI : 10.1093/nar/gkq537

D. Bjorling, J. Elkahwaji, and W. Bushman, Acute acrolein-induced cystitis in mice, BJU International, vol.291, issue.6, pp.1523-1532, 2007.
DOI : 10.1016/0891-5849(89)90137-8

R. Romih, D. Koprivec, D. Martincic, and K. Jezernik, RESTORATION OF THE RAT UROTHELIUM AFTER CYCLOPHOSPHAMIDE TREATMENT, Cell Biology International, vol.25, issue.6, pp.531-538, 2001.
DOI : 10.1006/cbir.2000.0658

P. Cox, Cyclophosphamide cystitis???Identification of acrolein as the causative agent, Biochemical Pharmacology, vol.28, issue.13, pp.2045-2054, 1979.
DOI : 10.1016/0006-2952(79)90222-3

J. Liu, M. Droller, and J. Liao, New Optical Imaging Technologies for Bladder Cancer: Considerations and Perspectives, The Journal of Urology, vol.188, issue.2, pp.361-369, 2012.
DOI : 10.1016/j.juro.2012.03.127
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035237

A. Lopez and J. Liao, Emerging Endoscopic Imaging Technologies for Bladder Cancer Detection, Current Urology Reports, vol.21, issue.18, p.406, 2014.
DOI : 10.1007/BF03262330
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043447

L. Mertens, Y. Neuzillet, S. Horenblas, and B. Van-rhijn, Landmarks in non-muscle-invasive bladder cancer, Nature Reviews Urology, vol.54, issue.8, pp.476-80, 2014.
DOI : 10.1016/j.eururo.2008.06.062

S. Lerner and A. Goh, Novel endoscopic diagnosis for bladder cancer, Cancer, vol.2, issue.11 pt B, pp.169-78, 2015.
DOI : 10.1364/BOE.2.000915
URL : http://onlinelibrary.wiley.com/doi/10.1002/cncr.28905/pdf

K. Lurie, A. Gurjarpadhye, E. Seibel, and A. Ellerbee, Rapid scanning catheterscope for expanded forward-view volumetric imaging with optical coherence tomography, Optics Letters, vol.40, issue.13, pp.3165-3173, 2015.
DOI : 10.1364/OL.40.003165

K. Lurie, R. Angst, D. Zlatev, J. Liao, E. Bowden et al., 3D reconstruction of cystoscopy videos for comprehensive bladder records, Biomedical Optics Express, vol.8, issue.4, pp.2106-2129, 2017.
DOI : 10.1364/BOE.8.002106

K. Lurie, R. Angst, E. Seibel, J. Liao, E. Bowden et al., Registration of free-hand OCT daughter endoscopy to 3D organ reconstruction, Biomedical Optics Express, vol.7, issue.12, pp.4995-5009, 2016.
DOI : 10.1364/BOE.7.004995

K. Lurie, G. Smith, S. Khan, J. Liao, and A. Ellerbee, Three-dimensional, distendable bladder phantom for optical coherence tomography and white light cystoscopy, Journal of Biomedical Optics, vol.19, issue.3, p.36009, 2014.
DOI : 10.1117/1.JBO.19.3.036009.2
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951584

G. Smith, K. Lurie, D. Zlatev, J. Liao, E. Bowden et al., Multimodal 3D cancer-mimicking optical phantom, Biomedical Optics Express, vol.7, issue.2, pp.648-62, 2016.
DOI : 10.1364/BOE.7.000648.v001
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771478

M. Mitsunaga, M. Ogawa, N. Kosaka, L. Rosenblum, P. Choyke et al., Cancer cell???selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules, Nature Medicine, vol.7576, issue.12, pp.1685-91, 2011.
DOI : 10.1002/jso.2930310402
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3233641

Y. Pan, J. Volkmer, and K. Mach, Endoscopic molecular imaging of human bladder cancer using a CD47 antibody, Science Translational Medicine, vol.7, issue.7, pp.260-148, 2014.
DOI : 10.4103/0970-1591.82839

S. Rebouissou, I. Bernard-pierrot, and A. De-reynies, EGFR as a potential therapeutic target for a subset of muscleinvasive bladder cancers presenting a basal-like phenotype, Science Translational Medicine, vol.6, pp.244-91, 2014.

C. Yeung, T. Dinh, and J. Lee, The Health Economics of Bladder Cancer: An Updated Review of the Published Literature, PharmacoEconomics, vol.52, issue.1, pp.1093-104, 2014.
DOI : 10.1016/j.eururo.2007.01.064

Y. Lotan, S. Shariat, and B. Schmitz-drager, Considerations on implementing diagnostic markers into clinical decision making in bladder cancer, Urologic Oncology: Seminars and Original Investigations, vol.28, issue.4, pp.441-449, 2010.
DOI : 10.1016/j.urolonc.2009.11.004

Y. Lotan, J. Raman, and S. Shariat, PI-LBA07 THE DEVELOPMENT AND CLINICAL VALIDATION OF A HIGH SENSITIVITY URINE BIOMARKER TEST FOR THE DETERMINATION OF RECURRENCE IN UROTHELIAL CARCINOMA PATIENTS, The Journal of Urology, vol.195, issue.4, p.1071, 2016.
DOI : 10.1016/j.juro.2016.03.130

C. Zhang, H. Yeh, M. Kuroki, and T. Wang, Single-quantum-dot-based DNA nanosensor, Nature Materials, vol.87, issue.11, pp.826-857, 2005.
DOI : 10.1038/nmat1508

Y. Zhang, S. Park, K. Liu, J. Tsuan, S. Yang et al., A surface topography assisted droplet manipulation platform for biomarker detection and pathogen identification, Lab Chip, vol.40, issue.3, pp.398-406, 2011.
DOI : 10.1128/JCM.40.9.3449-3454.2002
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626018

Y. Zhang and T. Wang, Full-Range Magnetic Manipulation of Droplets via Surface Energy Traps Enables Complex Bioassays, Advanced Materials, vol.113, issue.21, pp.2903-2911, 2013.
DOI : 10.1016/j.snb.2005.01.029
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964134

A. Stark, D. Shin, T. Pisanic, K. Hsieh, and T. Wang, A parallelized microfluidic DNA bisulfite conversion module for streamlined methylation analysis, Biomedical Microdevices, vol.11, issue.1, p.5, 2016.
DOI : 10.1039/C0LC00296H